| Degree | Department/Program | Institute | Year |
| BACHELOR'S DEGREE | PHARMACY | GAZI UNIVERSITY | 1989 |
| 1992 | |||
| 1996 |
1. Detection of nitric oxide synthetizing ability of macrophages from healthy and Mycobacterium tuberculosis infected people by using analytical and bioassay methods, Supervisor: Dr. Nurettin ABACIOĞLU, Gazi University, Graduate School of Health Sciences, Pharmacology Department, Ankara, Turkey, 1996.
1. 1. The role of respiratory epithelium on some bronchoconstrictor agents, Supervisor: Dr. Nurettin ABACIOĞLU, Gazi University, Graduate School of Health Sciences, Pharmacology Department, Ankara, Turkey, 1992.
| Title | Institute | Year |
| ASSOC. PROF. DR. | GAZI UNIVERSITY | 2000-11-03 - 2001-09-07 |
| ASSOC. PROF. DR. | MERSIN UNIVERSITY | 2001-09-09 - 2006-05-10 |
| PROF. DR. | MERSIN UNIVERSITY | 2006-05-11 - Continue |
| Title | Dutie | Institution/Other | Year |
| HEAD OF ETHICS COMMITTEE | MERSIN UNIVERSITY CLINICAL RESEARCH ETHICS COMITTEE | MERSIN UNIVERSITY | 2011-11-28 - Continue |
| 2016-01-11 - 2019-01-11 | |||
| 2016-01-11 - 2020-01-11 | |||
| 2015-12-25 - 2018-12-25 | |||
| 2015-12-25 - 2018-12-25 | |||
| 2015-12-25 - 2018-12-25 | |||
| 2012-12-25 - 2015-12-25 | |||
| 2012-12-25 - 2015-12-25 | |||
| 2012-12-25 - 2015-12-25 | |||
| 2012-12-25 - 2015-12-25 | |||
| 2012-06-18 - 2015-06-18 | |||
| 2012-06-18 - 2015-06-18 |
2018
1. CEVHER, F.; ÜNAL, S.; KÜÇÜKKAVRUK, Ş.; TAŞDELEN, B.; TUNÇTAN, B. . TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2018, 38, 30-39. 0 + 010.5336/medsci.2017-57070
2021
79. Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Tunctan, B. Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model. SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2021, 46, 624-637. 400 + 0
78. Cagli, A.; Senol, S.; Temiz‐Resitoglu, M.; Guden, D.; Sari, A.; Sahan‐Firat, S.; Tunctan, B. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl‐3‐(1‐propionylpiperidin‐4‐yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro‐inflammatory and anti‐inflammatory signaling pathways .... WILEY, 2021, 0-0. 200 + 0
77. Guden, D.; Temiz-Resitoglu, M.; Senol, S.; Kibar, D.; Yilmaz, S.; Tunctan, B.; Malik, K.; Sahan-Firat, S. mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats. CANADIAN SCIENCE PUBLISHING, 2021, 0-0. 250 + 0
2020
76. Biliktu, M.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Horat, M.; Sahan-Firat, S.; Sevim, S.; Tunctan, B. Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner. SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2020, 0-0. 100 + 0
75. Tunctan, B. CYP-derived eicosanoids in inflammatory diseases. ELSEVIER BV, 2020, 148, 106424-106424. 1000 + 0
2019
74. Kocak, Z.; Temiz-Resitoglu, M.; Guden, D.; Vezir, O.; Sucu, N.; Balcı, S.; Tamer-Gumus, L.; Tunctan, B.; Malik, K.; Sahan-Firat, S. Modulation of oxidative–nitrosative stress and inflammatory response by rapamycin in target and distant organs in rats exposed to hindlimb ischemia–reperfusion: the role of mammalian target of rapamycin. CANADIAN SCIENCE PUBLISHING, 2019, 97, 1193-1203. 100 + 0
73. Tunctan, B.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sahan-Firat, S.; Falck, J.; Malik, K. Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock. ELSEVIER BV, 2019, 145, 106377-106377. 800 + 0
72. Tunctan, B.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sahan-Firat, S.; Falck, J.; Malik, K. Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock. ELSEVIER BV, 2019, 145, 106377-106377. 800 + 0
71. ŞAHAN FIRAT, S.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; ŞENOL, Ş.; SARI, A.; ÇİL, M.; ÜNSAL, D.; KORKMAZ, B.; TUNÇTAN, B.; MALIK, K. NF-κB activation mediates LPS- or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46, 173-182. 100 + 0
2018
70. TUNÇTAN, B.; KÜÇÜKKAVRUK, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S. . INFLAMMATION, 2018, 41, 337-355. 850 + 0
69. ŞAHAN FIRAT, S.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; KÜÇÜKKAVRUK, Ş.; TUNÇTAN, B.; SARI, A.; KOÇAK, Z.; MALIK, K. . INFLAMMATION, 2018, 41, 276-298. 350 + 0
68. TUNÇTAN, B. . CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45, 155-165. 1000 + 0
2017
67. Temiz-Resitoglu, M.; Kucukkavruk, S.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A.; Tamer-Gumus, L.; Buharalioglu, C.; Malik, K. Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 802, 7-19. 150 + 0
66. Dolunay, A.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Tunctan, B. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. INFLAMMATION, 2017, 40, 366-386. 200 + 0
65. Tunctan, B.; Kucukkavruk, S.; Temiz Resitoglu, M.; Güden, D.; Sari, A.; Sahan Firat, S.; Paudyal, M.; Falck, J.; Malik, K. Inhibition of NLRP3 Inflammasome Contributes to Protective Effect of 5,14-HEDGE against Lipopolysaccharide-Induced Septic Shock. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13, 654-666. 700 + 0
2016
64. Senol, S.; Temiz, M.; Guden, D.; Cecen, P.; Sari, A.; Sahan-Firat, S.; Falck, J.; Dakarapu, R.; Malik, K.; Tunctan, B. Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock. INFLAMMATION RESEARCH , 2016, 65, 367-387. 100 + 0
2014
63. Tunctan, B. Inflammation and allergy. Editorial.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2014, 13, 1-2. 1000 + 0
62. Battal, D.; Cok, I.; Unlusayin, I.; Tunctan, B. Development and validation of an LC-MS/MS method for simultaneous quantitative analysis of free and conjugated bisphenol A in human urine. BIOMEDICAL CHROMATOGRAPHY, 2014, 28, 686-693. 650 + 10
Times Cited: 2
61. Kucuk, M.; Sucu, N.; Firat, S.; Aytacoglu, B.; Vezir, O.; Bozali, C.; Canacankatan, N.; Kul, S.; Tunctan, B. Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70, 1443-1451. 100 + 0
60. Sari, A.; Kacan, M.; Unsal, D.; Firat, S.; Buharalioglu, C.; Vezir, O.; Korkmaz, B.; Cuez, T.; Canacankatan, N.; Sucu, N. Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723, 234-245. 0 + 15
Times Cited: 3
59. Sari, A.; Korkmaz, B.; Serin, M.; Kacan, M.; Unsal, D.; Buharalioglu, C.; Firat, S.; Manthati, V.; Falck, J.; Malik, K. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKK beta/I kappa B-alpha/NF-kappa B pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. INFLAMMATION RESEARCH, 2014, 63, 741-756. 0 + 0
58. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B. Determination of urinary levels of Bisphenol A in a Turkish population. ENVIRONMENTAL MONITORING AND ASSESSMENT, 2014, 186, 8443-8452. 500 + 0
2013
57. Tunctan, B.; Sari, A.; Kacan, M.; Unsal, D.; Buharalioglu, C.; Sahan-Firat, S.; Korkmaz, B.; Falck, J.; Malik, K. NS-398 reverses hypotension in endotoxemic rats: Contribution of eicosanoids, NO, and peroxynitrite. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 104, 93-108. 700 + 0
56. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-Firat, S.; Cuez, T.; Schunck, W. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide:hydrolase, CYP2C23, MEK1/ERK1/2/IKK beta/IKB-alpha./NF-kappa B pathway, and proinflammatory. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 102, 31-41. 650 + 10
Times Cited: 2
55. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B. Determination of bisphenol A exposure in rural and urban areapopulations in Mersin City, Turkey. TOXICOLOGY LETTERS, 2013, 221, 103-103. 500 + 0
54. Tunctan, B. The latest advances in the use of conventional anti-inflammatory drugs and agents. Preface.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2013, 12, 1-1. 1000 + 15
Times Cited: 3
53. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-Firat, S.; Cuez, T.; Schunck, W. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2013, 33, 18-41. 650 + 15
Times Cited: 3
2012
52. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-Firat, S.; Schunck, W.; Falck, J. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 121-50. 650 + 25
Times Cited: 5
51. Tunctan, B. Drug discovery and development.Preface.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 1-1. 1000 + 0
50. Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Demiryurek, A.; Sahan-Firat, S.; Sari, A.; Tunctan, B. Contribution of MEK1/ERK1/2/iNOS pathway to oxidative stress and decreased caspase-3 activity in endotoxemic rats.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 243-52. 200 + 0
49. Sahan-Firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A.; Kacan, M.; Unsal, D.; Tunctan, B. Increased production of nitric oxide mediates selective organ-specific effects of endotoxin on oxidative stress.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 161-72. 100 + 0
48. Canacankatan, N.; Sucu, N.; Aytacoglu, B.; Gul, O.; Gorur, A.; Korkmaz, B.; Sahan-Firat, S.; Antmen, E.; Tamer, L.; Ayaz, L. Affirmative Effects of Iloprost on Apoptosis during Ischemia-Reperfusion Injury in Kidney as a Distant Organ. RENAL FAILURE, 2012, 34, 111-118. 0 + 20
Times Cited: 4
2011
47. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Sari, A.; Malik, K.; Tunctan, B. A SELECTIVE CYCLOOXYGENASE-1 INHIBITOR, PIROXICAM, REVERSES ENDOTOXIN-INDUCED HYPOTENSION IN RATS: CONTRIBUTION OF VASOACTIVE EICOSANOIDS AND NITRIC OXIDE. INFLAMMATION RESEARCH, 2011, 60, 150-151. 200 + 0
46. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Sari, A.; Malik, K.; Tunctan, B. Piroxicam Reverses Endotoxin-Induced Hypotension in Rats: Contribution of Vasoactive Eicosanoids and Nitric Oxide. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109, 186-194. 200 + 25
Times Cited: 5
45. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C.; Sahan-Firat, S.; Schunck, W.; Serin, M. CONTRIBUTION OF INOS, COX-2 AND CYP4A1 TO THE PROTECTIVE EFFECT OF A SYNTHETIC ANALOG OF 20-HETE, 5,14-HEDGE, AGAINST ENDOTOXIN-INDUCED HYPOTENSION AND MORTALITY IN EXPERIMENTAL MODEL OF SEPTIC SHOCK IN RATS AND MICE. INFLAMMATION RESEARCH, 2011, 60, 55-55. 650 + 15
Times Cited: 3
44. Korkmaz, B.; Buharalioglu, K.; Sahan-Firat, S.; Cuez, T.; Demiryurek, A.; Tunctan, B. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 24, 160-172. 400 + 50
Times Cited: 10
43. Serin, M.; Tiftik, N.; Karakaya, B.; Tunctan, B.; Dogen, A.; Tezcan, S.; Kaplan, E.; Aslan, G.; Emekdas, G.; Yalcin, A. HIGH PREVALANCE OF ANTI-DENGUE VIRUS IGG IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND POSSIBLE ROLE OF DENGUE VIRUS IN THROMBOSIS. INFLAMMATION RESEARCH, 2011, 60, 153-153. 350 + 0
2010
42. Cuez, T.; Korkmaz, B.; Buharalioglu, C.; Sahan-Firat, S.; Falck, J.; Malik, K.; Tunctan, B. A Synthetic Analogue of 20-HETE, 5,14-HEDGE, Reverses Endotoxin-Induced Hypotension via Increased 20-HETE Levels Associated with Decreased iNOS Protein Expression and Vasodilator Prostanoid Production in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106, 378-388. 200 + 55
Times Cited: 11
41. Tunctan, B.; Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Sahan-Firat, S.; Falck, J.; Malik, K. Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107, 877-882. 800 + 30
Times Cited: 6
2009
40. Korkmaz, B.; Buharalioglu, K.; Demiryurek, A.; Sahan-Firat, S.; Cuez, T.; Tunctan, B. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway contributes to the fall in blood pressure and vascular reactivity in endotoxemic rats. FASEB JOURNAL, 2009, 23, 0-0. 400 + 0
39. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Yildirim, H.; Tamer, L.; Buharalioglu, K.; Falck, J.; Malik, K. Increased production of 20-HETE contributes to the effects of COX inhibitors to prevent the decrease in lipid peroxidation and increase in catalase activity during endotoxemia. FASEB JOURNAL, 2009, 23, 0-0. 700 + 0
38. Buharalioglu, K.; Ozbasoglu, O.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Yalcin, A.; Tunctan, B. Thalidomide potentiates analgesic effect of COX inhibitors on endotoxin-induced hyperalgesia by modulating TNF-alpha, PGE and NO synthesis in mice. FASEB JOURNAL, 2009, 23, 0-0. 200 + 0
2008
37. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Sahan-Firat, S.; Anjaiah, S.; Falck, J.; Yildirim, H.; Tamer, L.; Roman, R.; Malik, K. 20-HETE agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the endotoxin-induced fall in blood pressure and the decrease in vascular reactivity and lipid peroxidation and increased catalase activity via inhibition of NO . FASEB JOURNAL, 2008, 22, 0-0. 650 + 0
36. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Firat, S.; Anjaiah, S.; Falck, J.; Roman, R.; Malik, K. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. SHOCK, 2008, 30, 329-335. 750 + 95
Times Cited: 19
35. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. ARCHIVES OF PHARMACAL RESEARCH, 2008, 31, 856-865. 950 + 40
Times Cited: 8
34. Sahan-Firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A.; Tunctan, B. Differential regulation of oxidative stress by NO in vascular and nonvascular tissues of endotoxemic rats. FASEB JOURNAL, 2008, 22, 0-0. 100 + 0
2007
33. Gunaydin, B.; Sancak, B.; Candan, S.; Sariahmetoglu, M.; Ozcagli, G.; Tunctan, B.; Cakici, I.; Akcabay, M. Temporal variation of oxidant stress in critically ill patients. MINERVA ANESTESIOLOGICA, 2007, 73, 261-266. 250 + 15
Times Cited: 3
32. Uludag, O.; Tunctan, B.; Altug, S.; Zengil, H.; Abacioglu, N. Twenty-four-hour variation of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway demonstrated by the mouse visceral pain model. CHRONOBIOLOGY INTERNATIONAL, 2007, 24, 413-424. 800 + 15
Times Cited: 3
31. Tunctan, B.; Korkmaz, B.; Dogruer, Z.; Tamer, L.; Atik, U.; Buharalioglu, C. Inhibition of extracellular signal-regulated kinase (ERK1/2) activity reverses endotoxin-induced hypotension via decreased nitric oxide production in rats. PHARMACOLOGICAL RESEARCH, 2007, 56, 56-64. 850 + 45
Times Cited: 9
2006
30. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tamer, L.; Degirmenci, U.; Atik, U. Nitric oxide reverses endotoxin-induced inflammatory hyperalgesia via inhibition of prostacyclin production in mice. PHARMACOLOGICAL RESEARCH, 2006, 53, 177-192. 800 + 65
Times Cited: 13
29. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14, 51-57. 950 + 65
Times Cited: 13
28. Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tunctan, B. Involvement of calcium/calmodulin-dependent protein kinase II to endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery. PHARMACOLOGICAL RESEARCH, 2006, 54, 208-218. 650 + 35
Times Cited: 7
27. Korkmaz, B.; Ozveren, E.; Buharalioglu, C.; Tunctan, B. Extracellular signal-regulated kinase (ERK1/2) contributes to endotoxin-induced hyporeactivity via nitric oxide and prostacyclin production in rat aorta. PHARMACOLOGY, 2006, 78, 123-128. 650 + 30
Times Cited: 6
26. Altug, S.; Uludag, O.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N. Biological time-dependent difference in effect of peroxynitrite demonstrated by the mouse hot plate pain model. CHRONOBIOLOGY INTERNATIONAL, 2006, 23, 583-591. 650 + 45
Times Cited: 9
2005
25. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C. Calcium/calmodulin dependent protein kinase II contributes to endotoxin-induced hyporeactivity via prostaglandin production in rat mesenteric artery. FASEB JOURNAL, 2005, 19, 1551-1551. 950 + 0
24. Tunctan, B.; Korkmaz, B.; Ozveren, E.; Buharalioglu, C. Mitogen-activated protein kinase signalling cascade contributes to endotoxin-induced hyporeactivity via nitric oxide and prostaglandin production in rat thoracic aorta. FASEB JOURNAL, 2005, 19, 1551-1551. 950 + 0
2004
23. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Prostagladins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. FASEB JOURNAL, 2004, 18, 1034-1035. 950 + 15
Times Cited: 3
22. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin induced hypotension in rats. FASEB JOURNAL, 2004, 18, 1037-1038. 950 + 0
21. Kiziltepe, U.; Tunctan, B.; Eyileten, Z.; Sirlak, M.; Arikbuku, M.; Tasoz, R.; Uysalel, A.; Ozyurda, U. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97, 93-100. 650 + 75
Times Cited: 15
2003
20. Tunctan, B.; Altug, S.; Uludag, O.; Demirkay, B.; Abacioglu, N. Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis. PHARMACOLOGICAL RESEARCH, 2003, 48, 37-48. 900 + 80
Times Cited: 16
2002
19. Yurdakul, A.; Calisir, H.; Tunctan, B.; Ogretensoy, M. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. RESPIRATORY MEDICINE, 2002, 96, 322-329. 750 + 135
Times Cited: 27
18. Tunctan, B.; Weigl, Y.; Dotan, A.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N. Circadian variation of nitric oxide synthase activity in mouse tissue. CHRONOBIOLOGY INTERNATIONAL, 2002, 19, 393-404. 800 + 115
Times Cited: 23
2001
17. Abacioglu, N.; Ozmen, R.; Cakici, I.; Tunctan, B.; Kanzik, I. Role of L-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51, 977-983. 600 + 60
Times Cited: 12
16. Abacioglu, N.; Tunctan, B.; Cakici, I.; Akbulut, E.; Uludag, O.; Kanzik, I. The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51, 832-838. 750 + 45
Times Cited: 9
2000
15. Abacioglu, N.; Demir, S.; Cakici, I.; Tunctan, B.; Kanzik, I. Role of guanylyl cyclase activation via thiamine in suppressing chemically-induced writhing in mouse. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2000, 50, 554-558. 600 + 50
Times Cited: 10
14. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N. Time-dependent variations in serum nitrite, 6-keto-prostaglandin F-1 alpha and thromboxane B-2 levels induced by lipopolysaccharide in mice. BIOLOGICAL RHYTHM RESEARCH, 2000, 31, 499-513. 950 + 50
Times Cited: 10
13. Hosgor-Basgut, B.; Basgut, E.; Soyak, G.; Tunctan, B.; Cakici, F.; Kanzik, I. Peroxynitrite produces relaxations on the rat anococcygeus muscle. LIFE SCIENCES, 2000, 67, 3123-3127. 550 + 10
Times Cited: 2
12. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N. Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. LIFE SCIENCES, 2000, 67, 2393-2401. 950 + 35
Times Cited: 7
11. Abacioglu, N.; Tunctan, B.; Akbulut, E.; Cakici, I. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse. LIFE SCIENCES, 2000, 67, 1127-1137. 850 + 150
Times Cited: 30
1999
10. Uludag, O.; Tuncan, B.; Guney, H.; Uluoglu, C.; Altug, S.; Zengil, H.; Abacioglu, N. Temporal variation in serum nitrite levels in rats and mice. CHRONOBIOLOGY INTERNATIONAL, 1999, 16, 527-532. 0 + 25
Times Cited: 5
1998
9. Tunctan, B.; Cakici, I.; Abacioglu, N.; Kanzik, I. Bradykinin-induced responses in a coaxial bioassay system composed of rat anococcygeus muscle and guinea pig trachea. GENERAL PHARMACOLOGY, 1998, 30, 477-482. 950 + 5
Times Cited: 1
8. Tunctan, B.; Uludag, O.; Altug, S.; Abacioglu, N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. PHARMACOLOGICAL RESEARCH, 1998, 38, 405-411. 950 + 245
Times Cited: 49
7. Tunctan, B.; Okur, H.; Calisir, C.; Abacioglu, H.; Cakici, I.; Kanzik, I.; Abacioglu, N. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. PHARMACOLOGICAL RESEARCH, 1998, 37, 219-226. 800 + 55
Times Cited: 11
6. Guney, H.; Gorgun, C.; Tunctan, B.; Uludag, O.; Hodoglugil, U.; Abacioglu, N.; Zengil, H. Circadian-rhythm-dependent effects of L-N-G-nitroarginine methyl ester (L-NAME) on morphine-induced analgesia. CHRONOBIOLOGY INTERNATIONAL, 1998, 15, 283-289. 600 + 65
Times Cited: 13
1997
5. Cakici, I.; Ulug, H.; Inci, S.; Tunctan, B.; Abacioglu, N.; Kanzik, I.; Sener, B. Antinociceptive effect of some amaryllidaceae plants in mice. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49, 828-830. 500 + 30
Times Cited: 6
1995
4. CAKICI, I.; MATARACI, N.; ERSOY, S.; TUNCTAN, B.; ABACIOGLU, N.; KANZIK, I. EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS WEB-2086 AND BN-50730 ON DIGOXIN-INDUCED ARRHYTHMIAS. PHARMACOLOGY & TOXICOLOGY, 1995, 76, 343-347. 550 + 15
Times Cited: 3
1994
3. CAKICI, I.; HURMOGLU, C.; TUNCTAN, B.; ABACIOGLU, N.; KANZIK, I.; SENER, B. HYPOGLYCEMIC EFFECT OF MOMORDICA-CHARANTIA EXTRACTS IN NORMOGLYCEMIC OR CYPROHEPTADINE-INDUCED HYPERGLYCEMIC MICE. JOURNAL OF ETHNOPHARMACOLOGY, 1994, 44, 117-121. 650 + 145
Times Cited: 29
1993
2. CAKICI, I.; TUNCTAN, B.; ABACIOGLU, N.; KANZIK, I. EPITHELIUM-DEPENDENT RESPONSES OF SEROTONIN IN A COAXIAL BIOASSAY SYSTEM. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236, 97-105. 850 + 20
Times Cited: 4
1. ABACIOGLU, N.; BEDIZ, A.; CAKICI, I.; TUNCTAN, B.; KANZIK, I. ANTINOCICEPTIVE EFFECTS OF H1-ANTIHISTAMINICS AND H2-ANTIHISTAMINICS IN MICE. GENERAL PHARMACOLOGY, 1993, 24, 1173-1176. 600 + 40
Times Cited: 8
2016
5. Senol, S.; Tiftik, E.; Unal, S.; Akdeniz, A.; Tasdelen, B.; Tunctan, B. Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy. JOURNAL OF BASIC AND CLINICAL PHARMACY, 2016, 7, 49-59. 80 + 0
2015
4. Tunctan, B. An overview of published papers and important developments in the past three years. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2015, 14, 2-12. 200 + 0
2013
3. Tunctan, B. 20-HETE mimetics or inhibitors in the treatment of cancer patients with sepsis and septic shock. INTERNATIONAL JOURNALS OF CANCER STUDIES & RESEARCH , 2013, 2, 101-108. 200 + 0
2005
2. Tunctan, B.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Atik, U.; Buharalioglu, C. Increased production of nitric oxide contributes to renal oxidative stress in endotoxemic rat. AMERICAN JOURNAL OF INFECTIOUS DISEASES , 2005, 1, 111-115. 170 + 0
2004
1. Tunctan, B.; Altug, S. The use of nitric oxide synthase inhibitors in inflammatory diseases: a novel class of anti-inflammatory agents. CURRENT MEDICINAL CHEMISTRY: ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS , 2004, 3, 271-301. 200 + 0
2017
16. Küçük, M.; Karaca, K.; Fırat, S.; Vezir, Ö.; Canacankatan, N.; Aytaçoğlu, B.; Erden, S.; Tunçtan, B.; Sucu, N. Koroner arter bypass cerrahisinde ramiprilin miyokardiyal hasar ve inflamatuvar yanıttaki etkisi üzerinde sitokin gen polimorfizmlerinin rolü. CUKUROVA MEDICAL JOURNAL, 2017, 42, 436-445. 20 + 0
2015
15. Şenol, Ş.; Tunçtan, B. The role of peroxisome proliferator-activated receptors in the pathogenesis of insulin resistance and septic shock. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2015, 5, 247-258. 200 + 0
14. Güden, D.; Temiz, M.; Tunçtan, B.; Şahan Fırat, S. Sepsis ve septik şok patojenezinde endotelin-1'in rolü ve tedavide yeni yaklaşımlar. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2015, 5, 178-190. 150 + 0
2014
13. Güden, D.; Tunçtan, B. The role of endothelin-1 in the pathogenesis of diabetes. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2014, 4, 158-167. 200 + 0
12. Ünsal, D.; Temiz, M.; Tunçtan, B.; Şahan-Fırat, S. Signal transduction of zymosan and spleen tyrosine kinase. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2014, 4, 148-157. 150 + 0
2010
11. Sarı, A.; Şahan-Fırat, S.; Tunçtan, B. Rho kinase and cardiovascular diseases. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , 2010, 3, 1-7. 200 + 0
2008
10. Şahan-Fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Sarı, A.; Tunçtan, B. Effect of inhibition of inducible nitric oxide synthase on the increased oxidative stress in the liver of endotoxemic rats. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , 2008, 1, 28-35. 40 + 0
2006
9. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N. Contribution of nitric oxide and tumor necrosis factor-a to the effect of indomethacin on the endotoxin-induced mortality. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , 2006, 30, 1-6. 190 + 0
2005
8. Tunctan, B. Nitric oxide decreases eicosanoid production via activation of guanylyl cyclase and polyADP-ribose synthase in endotoxin-stimulated whole blood, kidney and heart. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 2, 137-154. 200 + 0
7. Tunçtan, B.; Buharalıoğlu, C. Pharmacological Terminology Dictionary. SENDROM III, 2005, 3, 3-44. 200 + 0
2004
6. Tunçtan, B.; Aykanat, D.; Korkmaz, B.; Özveren, E.; Buharalıoğlu, C. Euthanasia methods for experimental animals. MERSIN UNIVERSITESI TIP FAKULTESI DERGISI , 2004, 1, 44-54. 180 + 0
2003
5. Kızıltepe, U.; Taşöz, R.; Aral, A.; Tunçtan, B.; Eyileten, Z.; Şırlak, M.; Emiroğulları, O.; Arıkbuku, M.; Eryılmaz, S.; Yazıcıoğlu, L. Efficiency of L-arginine cardioplegia and L-arginine supplemented non-cardiopegic blood in preventing of controlled reperfusions. MEDIKAL NETWORK KARDIYOLOJI , 2003, 10, 33-40. 70 + 0
2002
4. Taşöz, R.; Kızıltepe, U.; Eyileten, Z.; Tunçtan, B.; Şırlak, M.; Emiroğulları, O.; Eryılmaz, S.; Yazıcıoğlu, L.; Aral, A.; Eren, N. Myocardial nitric oxide metabolism and possible treatment options in open thoracic surgery. MEDIKAL NETWORK KARDIYOLOJI , 2002, 9, 345-351. 70 + 0
2000
3. Tunçtan, B. Role of nitric oxide synthase inhibitors in septic shock teatment. ILAC VE TEDAVI DERGISI, 2000, 13, 298-307. 200 + 0
1998
2. Tunçtan, B.; Abacıoğlu, N. Measurement of nitric oxide in biological samples: diazotization method. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 23, 161-170. 200 + 0
1993
1. Tunçtan, B.; Çakıcı, İ.; Abacıoğlu, N.; Kanzık, İ. Epithelium-derived relaxant factors and bronchial hypereactivity. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , 1993, 18, 71-76. 190 + 0
2017
2. Küçükkavruk, Ş.; Tunçtan, B. ---. TURK FARMAKOLOJI DERNEGI BULTENI, 2017, 136, 16-21. 50 + 0
2016
1. Şenol, Ş. Myocardial and renal ischemia/reperfusion injury and experimental models. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI, 2016, 5, 93-109. 0 + 0
1. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6 , Transworld Research Network, Number of print: 1000, Total Printing Number: 1, 8 Page, English, Kerala, India, 2012. 250
2. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6 , Transworld Research Network, Number of print: 1, Total Printing Number: 1000, 96 Page, English, Kerala, India, 2012. 500
1. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6, Transworld Research Network, Number of print: 1, Total Printing Number: 1000, 250 Page, English, Kerala, India, 2012. 250
1. Yeşilada, E.; Zülfikar, H.; Ertan, R.; Yakıncı, C.; Tunçtan, B.; Aktay, G.; Özkan, Y.; Aydın, A.; Küçükgüzel, İ.; Savaşer, A. Drug and Pharmacy Terms Dictionary, ISBN: 978-975-16-2838-1, Ertem Basım Yayın Dağıtım, Number of print: 2, Total Printing Number: 2000, 1032 Page, Turkish, Ankara, Turkey, 2015. 45
2. Tunçtan, B. Rational Drug Use in Pediatric Patients, ISBN: 978-605-60137-6-8 , Türk Eczacıları Birliği Eczacılık Akademisi, Yorum Matbaacılık, Number of print: 1, Total Printing Number: 1000, 120 Page, Turkish, Ankara, Turkey, 2012. 500
3. Yeşilada, E.; Zülfikar, H.; Ertan, R.; Yakıncı, C.; Tunçtan, B.; Aktay, G.; Özkan, Y.; Aydın, A.; Küçükgüzel, İ.; Savaşer, A. Drug and Pharmacy Terms Dictionary, ISBN: 978-975-16-2838-1, Atatürk Kültür, Dil ve Tarih Yüksek Kurumu Türk Dil Kurumu, Ertem Basım Yayın Dağıtım, Number of print: 1, Total Printing Number: 2000, 1001 Page, Turkish, Ankara, Turkey, 2014. 50
1. Tunçtan, B. Guideline for Pharmacists, ISBN: 978-975-8037-39-1, Fersa Ofset, Number of print: 1, Total Printing Number: 1100, 500 Page, Turkish, Ankara, Turkey, 2015. 0
2. Tunçtan, B. Preventive Health Guide, ISBN: 978-605-60137-5-1, Türk Eczacıları Birliği Eczacılık Akademisi, Mattek Matbaacılık Bas. Yay. Tan San. Tic. Ltd. Şti., Number of print: 2, Total Printing Number: 1000, 7 Page, Turkish, Ankara, Turkey, 2012. 4000
3. Buharalıoğlu, K.; Tunçtan, B. Medication Skill, ISBN: 978-605-60137-9-9, Türk Eczacıları Birliği Eczacılık Akademisi, Yorum Matbaacılık, Number of print: 1, Total Printing Number: 1000, 2 Page, Turkish, Ankara, Turkey, 2013. 0
4. Tunçtan, B. Preventive Health Guide, ISBN: 978-605-60137-5-1, Mattek Matbaacılık Bas. Yay. Tan San. Tic. Ltd. Şti., Number of print: 2, Total Printing Number: 1000, 768 Page, Turkish, Ankara, Turkey, 2014. 0
5. Tunçtan, B. Guideline for Pharmacists, ISBN: 978-975-8037-39-1, Türk Eczacıları Birliği Eczacılık Akademisi Yayını, Özyurt Matbaacılık, Number of print: 2, Total Printing Number: 25000, 528 Page, Turkish, Ankara, Turkey, 2016. 250
1. Tunçtan, B. Goodman and Gilman's Manual of Pharmacology and Therapeutics, ISBN: 978-975-277-676-0, Güneş Tıp Kitabevleri, Number of print: 2, Total Printing Number: 5000, 1220 Page, Turkish, Ankara, Turkey, 2017. 50
2. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B., Determination of bisphenol A exposure in rural and urban area populations in Mersin City. The 49th Congress of the European Societes of Toxicology (EUROTOX), 2013-09-01, 2013-09-04, Interlaken, Switzerland, 2013. 250
1. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C., Contribution of iNOS, COX-2 and CYP4A1 to the protective effect of a synthetic analog of 20-HETE, 5,14-HEDGE, against endotoxin-induced hypotension and mortality in experimental model of septic shock in rats and mice. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 325
20. Serin, M.; Tiftik, N.; Karakaya, B.; Tunctan, B.; Dogen, A.; Tezcan, S.; Kaplan, E., High prevalance of anti-dengue virus IGG in patients with venous thromboembolism and possible role of dengue virus in thrombosis. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 87
19. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Sari, A.; Malik, K.; Tunctan, B., A selective cyclooxygenase-1 inhibitor, piroxicam, reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 50
18. Sahan-Firat, S.; Korkmaz, B.; Cuez, T.; Ayaz, L.; Tamer, L.; Buharalioglu, C.; Sari, A., Prostaglandins contribute to endotoxin-induced increase in lipid peroxidation via nitric oxide production during endotoxemia in rats. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 25
17. Tunctan, B.; Kormaz, B.; Cuez, T.; Sahan-Firat, S.; Yildirim, H.; Tamer, L.; Buharalioglu, K., Increased production of 20-HETE contributes to the effects of COX inhibitors to prevent the decrease in lipid peroxidation and increase in catalase activity during endotoxemia. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 175
16. Buharalioglu, K.; Ozbasoglu, O.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Yalcin, A.; Tunctan, B., Thalidomide potentiates analgesic effect of COX inhibitors on endotoxin-induced hyperalgesia by modulating TNF-a, PGE and NO synthesis in mice. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 50
15. Korkmaz, B.; Buharalioglu, K.; Demiryurek, T.; Sahan-Firat, S.; Cuez, T.; Tunctan, B., Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway contributes to the fall in blood pressure and vascular reactivity in endotoxemic rats. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 100
14. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Sahan-Firat, S.; Anjaiah, S.; Falck, J.; Yildirim, H., 20-HETE agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the endotoxin-induced fall in blood pressure and the decrease in vascular reactivity and lipid peroxidation and increased catalase activity via inhibition of NO production in rats. Experimental Biology 2008, 2008-04-05, 2008-04-09, San Diego, United States of America, 2008. 162
13. Sahan-Firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A., Differential regulation of oxidative stress by NO in vascular and nonvascular tissues of endotoxemic rats. Experimental Biology 2008, 2008-04-05, 2008-04-09, San Diego, United States of America, 2008. 25
12. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C., Calcium/calmodulin dependent protein kinase II contributes to endotoxin-induced hyporeactivity via prostaglandin production in rat mesenteric artery. Experimental Biology 2005, 2005-03-31, 2005-04-05, San Diego, United States of America, 2005. 237
11. Tunctan, B.; Korkmaz, B.; Ozveren, E.; Buharalioglu, C., Mitogen-activated protein kinase signalling cascade contributes to endotoxin-induced hyporeactivity via nitric oxide and prostaglandin production in rat thoracic aorta. Experimental Biology 2005, 2005-03-31, 2005-04-05, San Diego, United States of America, 2005. 237
10. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K., Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. Experimental Biology 2004, 2004-04-17, 2004-04-21, Washington , United States of America, 2004. 237
9. Tunctan, B.; Yaghini, A.; Estes, A.; Malik, K., Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. Experimental Biology 2004, 2004-04-17, 2004-04-21, Washington , United States of America, 2004. 237
8. Soyak, G.; Hosgor, B.; Ademoglu, F.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N., Chrononociceptive pattern of melatonin with the interaction of morphine and L-nitroarginine methyl ester (L-NAME). Biological Rhythms and Medications Joint Meeting of The Eight International Conference of Chronopharmacology and Chronotherapeutics and The American Association for Medical Chronobiology and Chronotherapeutics, 1999-08-24, 1999-08-28, Williamsburg, United States of America, 1999. 125
7. Tunctan, B.; Weigl, Y.; Dotan, A.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N., Circadian variation of nitric oxide synthase activity in mice kidney, testis, aorta and lungs. Biological Rhythms and Medications Joint Meeting of The Eight International Conference of Chronopharmacology and Chronotherapeutics and The American Association for Medical Chronobiology and Chronotherapeutics, 1999-08-24, 1999-08-28, Williamsburg, United States of America, 1999. 200
6. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N., Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. 2nd European Congress of Pharmacology, 1999-07-03, 1999-07-07, Budapest, Hungary, 1999. 237
5. Tunctan, B.; Weigl, Y.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N., Circadian variation of nitric oxide synthase activity in mice brain. 2nd European Congress of Pharmacology, 1999-07-03, 1999-07-07, Budapest, Hungary, 1999. 212
4. Hosgor, B.; Basgut, E.; Soyak, G.; Tunctan, B.; Cakici, I.; Kanzik, I., Effects of peroxynitrite and 3-nitro-L-tyrosine on the rat anococcygeus muscle. Fourth European Congress of Pharmaceutical Sciences, 1998-09-11, 1998-09-13, Milan, Italy, 1998. 137
3. Abacioglu, N.; Zengil, H.; Uludag, O.; Tunctan, B.; Guney, Z., Chronorhythmicity of L-arginine in nociception with the interaction of H1-receptor blocker mepyramine. International Congress of Chronobiology, 1997-09-07, 1997-09-11, Paris, France, 1997. 150
2. Tunctan, B.; Cakici, I.; Abacioglu, N.; Kanzik, I., Epithelium-dependent responses of bradykinin in a co-axial bioassay system. Annual Congress of European Respiratory Society , 1993-09-25, 1993-09-29, Firenze, Italy, 1993. 237
1. Abacioglu, N.; Tunctan, B.; Cakici, I.; Kanzik, I., Effects of ovalbumin challenge on epithelium-dependent responses to serotonin in a co-axial bioassay system. Annual Congress of European Respiratory Society, 1992-08-29, 1992-09-03, Vienna, Austria, 1992. 212
2. GUDEN, D.; TEMIZ-RESITOGLU, M.; KÜÇÜKKAVRUK, S.; TUNCTAN, B.; ŞAHAN-FIRAT, S., Protective effect of mTOR inhibition on LPS-induced systemic inflammation and tissue injury: contribution of mTOR/IκB-α/NF-κB/HIF-1α signaling pathway and NADPH oxidase system activity. 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 120
1. TUNÇTAN, B., Transcription factors and CYP-derived eicosanoids as therapeutic targets in cardiovascular and renal inflammatory response caused by endotoxemia . PCS 2nd Annual World Congress of Cardiothoracic-Renal Diseases (WCCRD-2015), 2015-10-30, 2015-10-31, Varşova, Poland, 2015. 200
13. ŞENOL, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Inhibition of TLR4/MyD88/TAK1/NF-κB/COX-2 pathway activation contributes to protective effect of bexarotene, a selective RXRα agonist, against lipopolysaccharide-induced inflammatory hyperalgesia. XVIIIth Congress of the European Shock Society and IXth Congress of the Int’xxl Federation of Shock Societies, 2019-10-08, 2019-10-12, Chania, Crete, Greece, 2019. 40
12. GUDEN, D.; TEMIZ-RESITOGLU, M.; SENOL, S.; KIBAR, D.; YILMAZ, S.; TUNCTAN, B.; SAHAN-FIRAT, S., mTOR contributes to LPS-triggered neuroinflammation: Modulation of IκB-α/NF-κB/HIF-1α signaling pathway. 21st Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 21st Annual Meeting of the Association of the Clinical Pharmacology Germany (VKliPha), 2019-02-25, 2019-02-28, Stuttgart, Germany, 2019. 30
11. GÜDEN, D.; TEMİZ REŞİTOĞLU, M.; ŞENOL, Ş.; KİBAR, D.; YILMAZ, Ş.; TUNÇTAN, B.; ŞAHAN FIRAT, S., mTOR contributes to LPS-triggered neuroinflammation: Modulation of IκB-α/NF-κB/HIF-1α signaling pathway. 21st Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 21st Annual Meeting of the Association of the Clinical Pharmacology Germany (VKliPha), 2019-02-25, 2019-02-28, Stuttgart, Germany, . 30
10. TAŞDELEN, B.; TUNCTAN, B., Gözlemsel klinik çalışma tasarlarken dikkat edilmesi gereken hususlar. 17. Uluslararası Doğu Akdeniz Aile Hekimliği Kongresi - DAAHK, 2018-05-10, 2018-05-13, Adana, Turkey, 2018. 100
9. ŞAHAN FIRAT, S.; KOÇAK, Z.; TEMİZ-REŞİTOĞLU, M.; GÜDEN, D.; VEZİR, Ö.; SUCU, N.; BALCI, Ş., Role of mTOR/IκB-α/NF-κB pathway activation in ischemia/reperfusion-induced inflammatory response in rats. Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 10
8. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Paudyal, P., Contribution of NLRP3 inflammasome to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against LPS-induced septic shock in rats. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 70
7. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S., Protective effect of bexarotene, a selective RXRa agonist, against hypotension associated with inflammation and tissue injury linked to decreased circulating inos levels in a rat model of septic shock. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 85
6. TUNÇTAN, B., Targeting miRNAs in the treatment of cardiovascular and renal diseases . 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 100
5. Tunçtan, B.; Dolunay, A.; Senol, S.; Temiz Resitoglu, M.; Guden, D.; Sari, A.; Sahan Firat, S., Inhibition of NLRP3 inflammasome prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: contribution of NF-B, caspase-1/11, ASC, NADPH oxidase, and NOS isoforms. 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 80
4. Tunctan, B., Transcription factors and CYP-derived eicosanoids as therapeutic targets in cardiovascular and renal inflammatory response caused by endotoxemia. CS World Congress of Cardiothoracic-Renal Diseases-2015, 2015-10-30, 2015-10-31, Warsaw, Poland, 2015. 100
3. Tunctan, B.; Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Sahan-Firat, S.; Falck, J.; Malik, K., Interactions between cytochrome P4504A, cyclooxygenase and nitric oxide synthase during endotoxemia: therapeutic implications for inflammatory diseases. EHRLICH II - 2nd World Conference on Magic Bullets, Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich, 2008-10-03, 2008-10-05, Nurnberg, Germany, 2008. 80
2. Tunctan, B., Interactions between cyclooxygenase and nitric oxide synthase pathway: implications for therapeutic intervention in inflammatory diseases. II. Mediterranean Pharmacy Congress, 2006-10-13, 2006-10-15, Mersin, Turkey, 2006. 100
1. Tunctan, B., Role of a pharmacist in clinical research. I. International Mediterranean Pharmacy Congress, 2005-10-28, 2005-10-31, Mersin, Turkey, 2005. 100
31. BİLİKTÜ, M.; ŞENOL, Ş.; TEMİZ-REŞİTOĞLU, M.; GÜDEN, D.; HORAT, M.; ŞAHAN-FIRAT, S.; SEVİM, S., Seçici çözünebilir epoksit hidrolaz inhibitörü TPPU NLRC4/ASC/prokaspaz-1 inflamazom oluşumu ve etkinliği ile antienflamatuvar NLRC3 ekspresyonundaki değişikliklerin eşlik ettiği deneysel otoimmün ensefalomiyelit bulgularını azaltabilmektedir. 2nd International Turkic World Congress of Multiple Sclerosis, 2020-02-13, 2020-02-16, Antalya, Turkey, 2020. 5
30. Cağli, A.; ŞENOL, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Inhibition of soluble epoxide hydrolase prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: Contribution of NLRC4 Inflammasome, NLRC3, NOX, iNOS, and nNOS. XVIIIth Congress of the European Shock Society and IXth Congress of the Int’xxl Federation of Shock Societies, 2019-11-08, 2019-11-12, Chania, Crete, Greece, 2019. 10
29. Cağli, A.; ŞENOL, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Inhibition of soluble epoxide hydrolase prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: Contribution of NLRC4 Inflammasome, NLRC3, NOX, iNOS, and nNOS. 11th Congress of the European Pain Federation (EFIC), 2019-09-04, 2019-09-07, Valencia, Spain, . 10
28. Cagli, A.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Tunctan, B., Inhibition of soluble epoxide hydrolase prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: Contribution of NLRC4 Inflammasome, NLRC3, NOX, iNOS, and nNOS. Pain in Europe XI - the 11th Congress of the European Pain Federation EFIC, 2019-09-04, 2019-09-07, Valencia, Spain, 2019. 10
27. ŞENOL, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Inhibition of TLR4/MyD88/TAK1/NF-κB pathway activation contributes to protective effect of bexarotene, a RXRα agonist, against lipopolysaccharide-induced inflammatory hyperalgesia. 11th Congress of the European Pain Federation (EFIC), 2019-09-04, 2019-09-07, Valencia, Spain, 2019. 20
26. KUCUKKAVRUK, S.; TEMIZ-RESITOGLU, M.; GUDEN, D.; SARI, A.; SAHAN-FIRAT, S.; TUNÇTAN, B., Bexarotene, a RXRα agonist, prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice. 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 20
25. GÜDEN, D.; KOÇAK, Z.; TEMİZ-REŞİTOĞLU, M.; VEZİR, Ö.; SUCU, N.; BALCI, Ş.; TAMER GÜMÜŞ, L., Contribution of mTOR to oxidative stress leading to organ injury in a rat model of hindlimb ischemia/reperfusion. Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 5
24. Battal, D.; Çok, İ.; Aktaş Şüküroğlu, A.; Ünlüsayın, İ.; Tunçtan, B., Exposure of the Turkish population to bisphenol A, 4-t-octylphenol and 4-nonylphenol and: a pilot study. 2nd International Gazi Pharma Symposium Series (GPSS-2017), 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 25
23. ŞAHAN FIRAT, S.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; KÜÇÜKKAVRUK, Ş.; TUNÇTAN, B.; SARI, A.; KOÇAK, Z., Activation of mTOR/MEK1/ERK1/2/IKKβ/IκB-α//NF-ĸB p65 pathway contributes to zymosan-induced systemic inflammatory response in rats. 2nd International Gazi Pharma Symposium Series (GPSS-2017), 2017-10-11, 2017-10-13, ANKARA, Turkey, 2017. 20
22. TUNÇTAN, B.; KUCUKKAVRUK, S.; TETEMIZ-RESITOGLU, M.; GUDEN, D.; SARI, A.; SAHAN-FIRAT, S., Bir sıçan septik şok modelinde seçici bir RXRa agonisti olan beksaroten PPARa/b/g-RXRa heterodimerlerinin oluşumundaki artmanın aracılık ettiği enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir. . 17th Congress of European Shock Society: numerous "premières", 2017-09-13, 2017-09-15, Paris, France, 2017. 42
21. Sahan Firat, S.; Temiz-Resitoglu, M.; Guden, D.; Kucukkavruk, S.; Tunctan, B.; Sari, A.; Kocak, Z., Contribution of mTOR to Oxidative/Nitrosative Stress via NADPH Oxidase System Activation in Zymosan-Induced Systemic Inflammation in Rats. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 20
20. Sahan Firat, S.; Temiz Resitoglu, M.; Buharalioglu, C.; Guden, D.; Senol, S.; Sari, A.; Kacan, M., The role of IkB-a/NF-kB pathway activation in hypotension and inflammation reversed by BAY 61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 5
19. Temiz, M.; Senol, S.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A., Inhibition of mammalian target of rapamycin reverses lipopolysaccharide-induced hypotension and inflammation in rats. 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 7
18. Canacankatan, N.; Yilmaz, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B., Effect of iloprost, a prostacyclin derivate on apoptosis during ischemia-reperfusion injury in lung as a distant organ. 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 5
17. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Gilik, D.; Serin, M.; Buharalioglu, C., A synthetic analog of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension and mortality via increased expression and activities of CYP4A1 and CYP2C23 in a rodent model of septic shock: contribution of MEK1/ERK1/2/IKK/IB-/NF-B pathway and soluble epoxide hydrolase. The 1st Central and Eastern European Conference on Sepsis, the SepsEast 2012, 2012-09-19, 2012-09-23, Budapest, Hungary, 2012. 32
16. Canacankatan, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B.; Sahan-Firat, S., Iloprost, a prostacyclin analogue prevents limb ischemia-reperfusion injury by reducing apoptosis in rats. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 5
15. Tunctan, B.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C.; Sahan-Firat, S.; Korkmaz, B., NS-398, a selective COX-2 inhibitor, reverses endotoxin-induced hypotension via increased CYP4A1 expression and 20-HETE levels associated with decreased COX-2 and iNOS expression and/or activity in a rat model of septic shock. The 14th International Winter Eicosanoid Conference, 2012-03-11, 2012-03-14, Baltimore, United States of America, 2012. 35
14. Canacankatan, N.; Sucu, N.; Sahan-Firat, S.; Gorur, A.; Antmen, S.; Korkmaz, B.; Tunctan, B., Attenuation of ischemia-reperfusion injury by iloprost on apoptosis and antioxidant capacity in kidney as a distant organ. 3rd International Congress on Cell Membranbes and Oxidative Stress: Focus on Calcium Signalling and TRP Channels, 2010-06-22, 2010-06-27, Isparta, Turkey, 2010. 5
13. Korkmaz, B.; Cuez, T.; Sahin, N.; Tunctan, B., Analgesic activity of solid dispersions of ibuprofen. II. Mediterranean Pharmacy Congress, 2006-10-13, 2006-10-15, Mersin, Turkey, 2006. 32
12. Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tunctan, B., Inhibition of inducible nitric oxide synthase restores attenuation of endothelium-dependent and endothelium-independent relaxations in rat superior mesenteric artery exposed to endotoxin. 8th International Symposium on Pharmaceutical Sciences (ISOPS-8), 2006-06-13, 2006-06-16, Ankara, Turkey, 2006. 32
11. Kiziltepe, U.; Bastuzel Eyileten, Z.; Tunctan, B.; Sirlak, M.; Emiroglu, O.; Tasoz, R.; Uysalel, A., Changes on systemic and cardiac nitric oxide production during open heart surgery. 52nd International Congress of the European Society for Cardiovascular Surgery, 2003-11-07, 2003-11-10, İstanbul, Turkey, 2003. 27
10. Kiziltepe, U.; Bastüzel Eyileten, Z.; Tunctan, B.; Sirlak, M.; Arikbuka, M.; Tasoz, R.; Uysalel, A., Efficiency of L-arginine supplemented cardioplegia and L-arginine supplemented non-cardiopegic blood controlled reperfusion for myocardial protection. 52nd International Congress of the European Society for Cardiovascular Surgery, 2003-11-07, 2003-11-10, İstanbul, Turkey, 2003. 27
9. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tamer, L.; Atik, U., Role of NFk-B and nitric oxide synthase in endotoxin-induced inflammatory hyperalgesi. 17th National Congress of Pharmacology, 1st Clinical Pharmacology Symposium & Joint Meeting of the Turkish & Dutch Pharmacological Societies, 2003-10-17, 2003-10-21, Antalya, Turkey, 2003. 42
8. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K., Inhibition by nitric oxide of cytochrome P450 4A expression and activity contributes to endotoxin-induced hypotension in rats. 17th National Congress of Pharmacology, 1st Clinical Pharmacology Symposium & Joint Meeting of the Turkish & Dutch Pharmacological Societies, 2003-10-17, 2003-10-21, Antalya, Turkey, 2003. 47
7. Eksioglu, U.; Tunctan, B.; Yalvac, I.; Babul, A.; Midillioglu, I.; Duman, S., Elevated aqueous humor nitric oxide levels differ in patients with different types of glaucoma. 4th International Glaucoma Symposium, 2003-03-19, 2003-03-22, Barcelona, Spain, 2003. 37
6. Gunaydin, B.; Sancak, B.; Candan, S.; Sariahmetoglu, M.; Ozcagli, G.; Tunctan, B.; Cakici, I., Temporal variation of oxidant stress in critically ill patients versus healthy subjects: Preliminary results. 25th Conference of International Society for Chronobiology, 2001-10-09, 2001-10-13, Antalya, Turkey, 2001. 12
5. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N., Day-night variations in nitric oxide production and mortality-induced by lipopolysaccharide in mice. The 4th Congress of Toxicology in Developing Countries, 1999-11-06, 1999-11-10, Antalya, Turkey, 1999. 47
4. Altug, S.; Uludag, O.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N., The bizarre chrononociceptive pattern of peroxynitrite. Second International Meeting on Pharmacy and Pharmaceutical Sciences, 1998-09-06, 1998-09-09, İstanbul, Turkey, 1998. 32
3. Uludag, O.; Tunctan, B.; Altug, S.; Zengil, H.; Abacioglu, N., Chemically-induced algesia in mice: L-arginine/NO/cGMP cascade and the rhythmicity of nitrite levels. International Conference. Nitric Oxide: Peripheral and Central Action, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 40
2. Uludag, O., Chemically-induced algesia in mice: is there a nociceptive rhythmic pattern in L-arginine/NO/cGMP cascade?. International Conference. Nitric Oxide: Peripheral and Central Action, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 0
1. Ozmen, M.; Col, C.; Cinel, I.; Isman, F.; Cinel, L.; Tunctan, B.; Berberoğlu, M., The correlation between reactive O2 species and histopathology of abdominal organs under increased insufflation pressure. Joint Euro-Asian Congress of Endoscopic Surgery, 1997-06-17, 1997-06-21, İstanbul, Turkey, 1997. 15
1. TUNÇTAN, B.; KÜÇÜKKAVRUK, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; FIRAT, S., Sıçanlarda oluşturulan deneysel septik şok modelinde seçici bir RXRa agonisti olan beksaroten enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir. . 24. Ulusal Farmakoloji Kongresi, 2017-10-17, 2017-10-20, Trabzon, Turkey, 2017. 42
19. ŞENOL, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Seçici RXRα agonisti beksarotenin lipopolisakkarit ile farelerde oluşturulan inflamatuvar hiperaljeziyi önleyici etkisine TLR4/MyD88/TAK1/NF-κB/COX-2 yolu etkinliğinin inhibisyonu katkıda bulunmaktadır. 25. Ulusal Farmakoloji Kongresi, 2019-11-04, 2019-11-07, Aydın, Turkey, 2019. 20
18. Cağli, A.; ŞENOL, Ş.; GÜDEN, D.; SARI, A.; ŞAHAN FIRAT, S.; TUNÇTAN, B., Seçici çözünebilir epoksit hidrolaz inhibitörü TPPU’xxnun lipopolisakkarit ile farelerde oluşturulan enflamatuvar hiperaljeziyi önleyici etkisine NLRC4 inflamazomu ve antienflamatuvar NLRC3’xxün katkısı. 25. Ulusal Farmakoloji Kongresi, 2019-11-04, 2019-11-07, Aydın, Turkey, 2019. 20
17. Temiz, M.; Şenol, Ş.; Güden, D.; Çeçen, P.; Sarı, A.; Tunçtan, B.; Gorur, A., Endotoksemik sıçanlarda ortaya çıkan sistemik inflamatuvar yanıtta mTOR/IκB-α/NF-κB yolu etkinliğinin rolü. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 7
16. Şenol, Ş.; Temiz, M.; Güden, D.; Çeçen, P.; Sarı, A.; Şahan Fırat, S.; Falck, J., Sıçanlarda oluşturulan deneysel septik şok modelinde 20-HETE mimetik 5,14-HEDGE'nin hipotansiyon, taşikardi ve enflamasyona karşı koruyucu etkisine PPARα/β/γ, AP-1, importin-α3 ve RXRα'nın katkısı. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 5
15. Tunçtan, B., Çocuklarda ilaç kullanımı. 12. Türkiye Eczacılık Kongresi, 2014-09-25, 2014-09-27, Ankara, Turkey, 2014. 50
14. Kaçan, M.; Ünsal, D.; Temiz, M.; Korkmaz, B.; Sarı, A.; Şahan Fırat, S.; Yıldırım Yaroğlu, H., Sıçanlarda lipopolisakkarit ile oluşan enflamasyon ve hipotansiyona dalak tirozin kinazının katkısının araştırılması. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 5
13. Sarı, A.; Korkmaz, B.; Serin, M.; Kaçan, M.; Ünsal, D.; Buharalıoğlu, C.; Şahan Fırat, S., Sıçanlarda oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE'nin yararlı etkilerine MyD88/TAK1/IKKβ/NF-B yolu etkinliği ile birlikte sistemik miR-150, miR-223 ve miR-297 ekspresyon düzeylerindeki azalmanın katkısı. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 5
12. Tunçtan, B., Septik şoklu hastalarda çoklu organ yetmezliği ve mortalitenin önlenmesi açısından tedavi yaklaşımları: Nitrik oksit sentaz inhibitörleri mi? Nitrik oksit vericileri mi? Nitrik oksit mi?. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 50
11. Urhan Küçük, M.; Sucu, N.; Şahan Fırat, S.; Aytaçoğlu, B.; Vezir, Ö.; Bozali, C.; Canacankatan, N., Ramiprilin koroner arter by pass cerrahisi hastalarında inflamatuar yanıt ve miyokardiyal hasara etkisinde ACE I/D gen polimorfizminin rolü. XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2013-10-27, 2013-10-30, Aydın, Turkey, 2013. 5
10. Sarı, A.; Kaçan, M.; Gilik, D.; Şahan Fırat, S.; Buharalıoğlu, C.; Vezir, Ö.; Korkmaz, B., Sıçanlarda oluşturulan periferik iskemi/reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesine RhoA/Rho-kinaz/ERK1/2/iNOS/NADPH oksidaz yolunun katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 5
9. Tunçtan, B.; Korkmaz, B.; Cüez, T.; Sarı, A.; Kaçan, M.; Gilik, D.; Buharalıoğlu, C., Sıçan ve farelerde oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE'nin hipotansiyonu ve mortaliteyi önleyici etkisine iNOS, COX-2, CYP4A1 ve NADPH oksidazın katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 32
8. Tunçtan, B.; Cüez, T.; Korkmaz, B.; Şahan Fırat, S.; Buharalıoğlu, C.; Yıldırım, H.; Sarı, A., Endotoksemik sıçanlarda NO oluşumundaki artmaya 20-HETE düzeylerindeki azalmanın eşlik ettiği oksidatif stres ve inflamasyon üzerinde yapay bir 20-HETE analoğu olan N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 32
7. Korkmaz, B.; Cüez, T.; Buharalıoğlu, C.; Demiryürek, A.; Şahan Fırat, S.; Sarı, A.; Tunçtan, B., Endotoksemik sıçanlarda gelişen kaspaz-3 aracılıklı apoptoza ve oksidatif strese MEK1/ERK1/2/iNOS yolunun katkısı. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 10
6. Tunçtan, B.; Korkmaz, B.; Buharalıoğlu, K.; Şahan Fırat, S.; Anjaiah, S.; Falck, J.; Roman, R., Endotoksin ile oluşan nitrik oksit aracılıklı hipotansiyon ve vasküler hiporeaktivite üzerinde selektif 20-hidroksieikozatetraenoik asit agonisti N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkileri. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 37
5. Korkmaz, B.; Buharalıoğlu, K.; Demiryürek, A.; Şahan Fırat, S.; Tunçtan, B., Endotoksemik sıçanların torasik aortasında gelişen vasküler hiporeaktiviteye indüklenebilir nitrik oksit sentaz/çözünebilir guanilil siklaz/protein kinaz G yolunun katkısı. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 25
4. Korkmaz, B.; Özveren, E.; Buharalıoğlu, C.; Tunçtan, B., Sıçan torasik aortunda endotoksin ile oluşan nitrik oksit ve prostaglandin aracılıklı hiporeaktiviteye mitojen ile aktive edilen protein kinaz sinyal ileti yolu katkıda bulunur. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 32
3. Tunçtan, B.; Özveren, E.; Korkmaz, B.; Buharalıoğlu, C.; Tamer, L.; Değirmenci, U.; Değirmenci, U., Endotoksin ile oluşan nitrik oksit aracılıklı inflamatuvar hiperaljezide nükleer transkripsiyon faktörü k B, siklooksijenaz ve poli-ADP-riboz sentazın rolü. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 40
2. Tunçtan, B.; Demirkay, B.; Okur, H., Fare kan, böbrek, kalp ve akciğer kültüründe indüklenebilir nitrik oksit sentaz aktivitesi üzerinde guanilil siklaz, siklooksijenaz ve poliADP-riboz sentazın rolü. XVI. Ulusal Farmakoloji Kongresi, 2001-10-01, 2001-10-05, İzmir, Turkey, 2001. 50
1. Tunçtan, B.; Altuğ, S.; Uludağ, U.; Demirkay, B.; Abacıoğlu, N., Endotoksin ile farede oluşturulan septik şok modelinde mortalite, serum nitrit düzeyleri ve doku nitrik oksit sentaz aktivitesi üzerine siklooksijenaz inhibitörlerinin etkisi. XVI. Ulusal Farmakoloji Kongresi, 2001-10-01, 2001-10-05, İzmir, Turkey, 2001. 45
45. Cevher, F.; Ünal, S.; Küçükkavruk, Ş.; Taşdelen, B.; Tunçtan, B., Hidroksiüre tedavisi alan orak hücre hastalığı olan pediatrik ve genç erişkin hastalarda yaşam kalitesi, klinik etkinlik ve tedaviden memnuniyetin değerlendirilmesi. 24. Ulusal Farmakoloji Kongresi, 2017-10-17, 2017-10-20, Trabzon, Turkey, 2017. 12
44. Ünsal, D.; Kaçan, M.; Temiz, M.; Güden, D.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C., Sıçanlarda Dtk/IκB-α/NF-κB yolu etkinliğindeki artışın zimosanın neden olduğu inflamatuvar yanıta katkısı. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 2
43. Şenol, P.; Tiftik, N.; Ünal, S.; Akdeniz, A.; Taşdelen, B.; Tunçtan, B., Beta talasemi majör ve orak hücreli anemi hastalarında demir şelatörlerine uyuncun karşılaştırılması. 1. Talasemi ve Hemoglobinopatiler Kongresi, 2014-11-20, 2014-11-23, İzmir, Turkey, 2014. 10
42. Ordu, H.; Temiz, T.; Tunçtan, B.; Şahan-Fırat, S., Sağlığın sembolü: Gılgamış Destanı'ndan Asklepios'a yılan. XI. Türk Eczacılık Tarihi Toplantısı, 2014-05-25, 2014-05-28, Kayseri, Turkey, 2014. 18
41. Ünsal, D.; Kaçan, M.; Temiz, M.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C.; Yıldırım Yaroğlu, H., Sıçanlarda zimosanın neden olduğu enflamasyon ve hipotansiyona dalak tirozin kinazının katkısı. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 2
40. Serin, M.; Tiftik, N.; Karakaya, B.; Tunçtan, B.; Döğen, A.; Tezcan, S.; Kaplan, E., Dengue virusunun (DENV) venöz tromboembolizmde yeri olan ADAMTS13 eksikliğindeki olası rolünün araştırılması. 7. Tanısal ve Moleküler Mikrobiyoloji Kongresi, 2012-06-05, 2012-06-08, Ankara, Turkey, 2012. 8
39. Görür, A.; Canacankatan, N.; Gül, E.; Algül, Ö.; Erdoğan, E.; Korkmaz, B.; Şahan-Fırat, S., Hepatoselüler karsinom gelişim sürecinde bazı benzimidazol türevlerinin antioksidan kapasite üzerine etkisi. 23. Ulusal Biyokimya Kongresi, 2011-11-29, 2011-12-02, Adana, Turkey, 2011. 2
38. Buharalıoğlu, C.; Sarı, A.; Kaçan, M.; Gilik, D.; Korkmaz, B.; Cüez, T.; Şahan Fırat, S., Endotoksemik sıçanlarda piroksikamın hipotansiyonu önleyici etkisine MEK1/ERK1/2/iNOS/NADPH oksidaz yolunun katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 2
37. Cüez, T.; Korkmaz, B.; Buharalıoğlu, C.; Şahan Fırat, S.; Falck, J.; Malik, K.; Tunçtan, B., Endotoksemik sıçanlarda N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin eNOS, iNOS ve hsp90 protein ekspresyonu ile prostanoit ve 20-HETE düzeyleri üzerindeki etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 5
36. Sarı, A.; Şahan Fırat, S.; Vezir, Ö.; Yılmaz, Ş.; Korkmaz, B.; Cüez, T.; Canacankatan, N., Seçici Rho-kinaz inhibitörü Y-27632'nin sıçanlarda oluşturulan periferik iskemi/reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesi üzerindeki etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 2
35. Sahan Fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Buharalıoğlu, K.; Tunçtan, B., Endotoksemik sıçanların karaciğerinde artan oksidatif stres üzerinde indüklenebilir nitrik oksit sentaz inhibisyonunun etkisi. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 5
34. Buharalıoğlu, C.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Atik, U.; Tunçtan, B., Nitrik oksidin böbrek sitozolik fosfolipaz A2 aktivitesini azaltıcı etkisi endotoksin ile oluşan hipotansiyona katkıda bulunabilir. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 10
33. Bayhan, A.; Menemenci, M.; Sivri, B.; Taş, E.; Buharalıoğlu, C.; Tunçtan, B., Akılcı ilaç kullanımında eczacının rolü. II. Ulusal Eczacılık Öğrenci Kongresi, 2004-10-03, 2004-10-04, Mersin, Turkey, 2004. 10
32. Apçin, Y.; Savur, H.; Soytoprak, S.; Buharalıoğlu, C.; Tunçtan, B., Günümüzde klinik eczacı ve klinik eczacılık. II. Ulusal Eczacılık Öğrenci Kongresi, 2004-10-03, 2004-11-04, Mersin, Turkey, 2004. 12
31. Yeni, G.; Bal, E.; Palangalı, E.; Buharalıoğlu, C.; Tunçtan, B., Yeni bin yılda ilaç sanayi ve eczacı. I. Ulusal Eczacılık Öğrenci Kongresi, 2003-10-03, 2003-10-04, Mersin, Turkey, 2003. 12
30. Yalın, S.; Şahin, N.; Yüksel, A.; Buharalıoğlu, C.; Tunçtan, B., Günümüzde klinik eczacı ve klinik eczacılık. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12
29. Buharalıoğlu, C.; Yüksel, A.; Şahin, N.; Yalın, S.; Tunçtan, B., ATC (Anatomical Therapeutic Chemical) ilaç sınıflandırma sistemi ve akılcı ilaç kullanımındaki rolü. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12
28. Şahin, N.; Yalın, S.; Yüksel, A.; Buharalıoğlu, C.; Tunçtan, B., 21. Yüzyılda hastalıkların tedavisinde yeni bir yaklaşım: Gen tedavisi ve farmakogenomik. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12
27. Şahan, L.; Günal, H.; Göktaş, U.; Leblebici, F.; Şavkılıoğlu, E.; Tunçtan, B., Kombine ve genel anestezinin hemodinami, oksijenizasyon ve nitrik oksit (NO) üzerine etkileri. Türk Anesteziyoloji ve Reanimasyon Derneği XXXV. Kongresi, 2001-10-27, 2001-10-31, Antalya, Turkey, 2001. 10
26. Soyak, G.; Hoşgör, B.; Ademoğlu, F.; Tunçtan, B.; Çakıcı, İ.; Abacıoğlu, N., Melatoninin kronosisepsiyondaki etkileri. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 13
25. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Günün farklı saatlerinde lipopolisakkarit uygulanmasının fare serum nitrit, 6-k-PGF1a ve TxB2 düzeylerinde oluşturduğu güniçi değişiklikler. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23
24. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Septik şok tedavisinde ekonazol yararlı olabilir mi? . XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23
23. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Lipopolisakkarit ile farede oluşturulan septik şok modelinde indometazinin oluşturduğu serum nitrit düzeyleri ve mortaliteye pentoksifilinin etkisi. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23
22. Tunctan, B.; Uludag, O.; Altug, S.; Abacioglu, N., Is nitric oxide synthase inhibition beneficial in lipopolysaccharide-induced sepsis in mice?. International Conference. Nitric Oxide: Peripheral and Central Actions, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 23
21. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., L-arjinin ve mepiramin etkileşmesiyle indüklenen nosiseptif proseslerde gözlenen güniçi değişiklikler (VI). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
20. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Mepiramin ve L-NAME etkileşmesiyle indüklenen antinosiseptif aktivitenin ve serum nitrit düzeylerinin kronoritmisite kalıbı (VII). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
19. Tunçtan, B.; Uludağ, O.; Altuğ, S.; Abacıoğlu, N., iNOS ve COX-2 inhibisyonunun LPS ile farede oluşturulan septik şok modelindeki rolü. XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 23
18. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde L-NAME’in etkileri ve serum nitrit düzeylerinin kronoritmisitesi (III). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
17. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-BK ile oluşturulan abdominal konstriksiyon modelinde metilen mavisinin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (V). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
16. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Sodyum nitroprusid ve mepiramin ile indüklenen antinosiseptif aktivite ve serum nitrit düzeylerinin kronoritmisite kalıbı (VIII). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
15. Uludağ, O.; Altuğ, S.; Tunçtan, B.; Zengil, H.; Abacıoğlu, N., L-arjinin/nitrik oksit kaskadında rolü olan ajanların fare serum nitrit düzeylerinin pik ve çukur değerlerin kronoritmisitesi bakımından mepiramin ile etkileşmesi (X). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 17
14. Tunçtan, B.; Uludağ, O.; Çalışır, C.; Abacıoğlu, H.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Aktif pulmoner tüberkülozlu hastaların serum nitrit ve TNFa düzeyleri üzerine antitüberküloz tedavinin etkisi. XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
13. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Sodyum nitroprusid ile indüklenen antinosiseptif aktivite ve serum nitrit düzeylerinin sirkadiyan ritmisitesi (IV). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
12. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde mepiraminin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (I). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
11. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Guanilil siklaz inhibisyonunun mepiramin kronoantinosisepsiyonunda ve serum nitrit düzeyleri üzerine etkisi (IX). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20
10. Abacıoğlu, N.; Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde L-arjinin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (II). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 17
9. Abacıoğlu, N.; Uludağ, O.; Tunçtan, B.; Güney, H.; Zengil, H., Nosisepsiyonda L-arjininin doza bağımlı trifazik etkisi ve 1. fazın kronoritmisitesi. 2. Ulusal Toksikoloji Kongresi, 1997-04-03, 1997-04-06, Antalya, Turkey, 1997. 17
8. Güney, H.; Görgün, C.; Tunçtan, B.; Uludağ, O.; Hodoğlugil, U.; Abacıoğlu, N.; Zengil, H., L-nitroarginin metil ester (L-NAME), morfin analjezisini zaman bağımlı olarak etkiliyor. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 15
7. Tunçtan, B.; Okur, H.; Çalışır, C.; Abacıoğlu, H.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Sağlıklı ve aktif pulmoner tüberkülozlu bireylerin monosit/makrofajlarında nitrik oksit oluşumunun diazotizasyon ve biyoesey yöntemleri ile karşılaştırılması. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1196. 20
6. Akbulut, E.; Tunçtan, B.; Uludağ, O.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Piridoksinin antinosiseptif etkisinde nitrik oksidin rolü. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 18
5. Güney, H.; Tunçtan, B.; Uluoğlu, C.; Uludağ, O.; Abacıoğlu, N.; Zengil, H., Sıçanlarda serum nitrit düzeylerindeki zaman bağımlı değişikliklerin incelenmesi. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 18
4. Uludağ, O.; Tunçtan, B.; Zengil, H.; Abacıoğlu, N., Farelerde güniçi serum nitrit düzeylerinin p-benzokinon (p-BK) ile değişiminin incelenmesi. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 21
3. Akbulut, E.; Abacıoğlu, N.; Demir, S.; Çakıcı, İ.; Tunçtan, B.; Kanzık, İ.; Demiryürek, A., Farede tiamin ve morfinin oluşturduğu antinosiseptif aktiviteye L-arjinin/NO-sGMP yolağının katkısı. XII. Ulusal Farmakoloji Kongresi, 1994-10-31, 1994-11-04, Antalya, Turkey, 1994. 10
2. Tunçtan, B.; Abacıoğlu, N.; Özmen, R.; Çakıcı, İ.; Kanzık, İ.; Demiryürek, A., Farede mepiramin ve morfinin oluşturduğu antinosiseptif aktiviteye L-arjinin ve NG-monometil-L-arjininin katkısı. XII. Ulusal Farmakoloji Kongresi, 1994-10-31, 1994-11-04, Antalya, Turkey, 1994. 21
1. Tunçtan, B.; Çakıcı, İ.; Abacıoğlu, N.; Kanzık, I., Bazı agonistlerin etkileri üzerinde solunum yolu epitelinin rolü. XI. Ulusal Farmakoloji Kongresi, 1992-11-04, 1992-11-08, Nevşehir, Turkey, 1992. 23
33. Investigation of the effect of 20-HETE mimetic 5,14-HEDGE on GPR75/Gaq/11 signalling pathway in lipopolysaccharide-induced systemic inflammation model in rats, BAP, Project Number: 2019-1-AP3-3471, 23000 TL, Manager, Continue... 100
32. Investigation of the effect of RXR agonist bexarotene on TLR4/MyD88-dependent pro-inflammatory and antiapoptotic signaling pathways in endotoxemic mice, BAP, Project Number: 2021-1-TP2-4299, 15000 TL, Manager, Continue... 100
31. Investigation of the effect of soluble epoxide hydrolase inhibition in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in experimental autoimmune encephalomyelitis model in mice, BAP, Project Number: 2019-1-TP2-3142, 9936 TL, Manager, Continue... 100
30. Investigation of the effect of docosahexaenoic acid on TRAF6/IKK/NF-kB pathway in relation to antiinflammatory NLRX1 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, TÜBİTAK, Project Number: 219S353, 45000 TL, Manager, 2021,Completed. 100
29. Investigation of the effect of selective RXRα agonist, bexarotene, on TLR4/MyD88/TAK1/NF-κB/COX-2 pathway in relation to proinflammatory cytokine production in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, BAP, Project Number: 2018-1-TP3-2814, 21000 TL, Manager, 2020,Completed. 100
28. Investigation of the effect of soluble epoxide hydrolase inhibition in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, BAP, Project Number: 2018-3-TP2-3082, 11000 TL, Manager, 2019,Completed. 100
27. Lipopolisakkarit ile farelerde oluşturulan inflamatuvar hiperaljezi modelinde seçici RXRα agonisti beksarotenin TLR4/MyD88/TAK1/NF-κB/COX-2 yolu üzerindeki etkisinin proinflamatuvar sitokin oluşumu ile ilişkilendirilerek araştırılması , TÜBİTAK, Project Number: 217S235, 30000 TL, Manager, 2019,Completed. 100
26. Investigation of the effect of selective RXRα agonist, bexarotene, on iNOS and CYP4F6 expression and activity in lipopolysaccharide-induced systemic inflammation model, TÜBİTAK, Project Number: 215S679, 220000 TL, Manager, 2018,Completed. 100
25. Investigation of the effect of 20-HETE mimetic, 5,14-HEDGE, on NLRP3/ASC/pro-caspase-1 inflammasome formation and activity in lipopolysaccharide-induced septic shock model in rats, BAP, Project Number: 2015-AP3-1343, 20000 TL, Manager, 2017,Completed. 100
24. Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, TÜBİTAK, Project Number: 215S047, 30000 TL, Manager, 2016,Completed. 100
23. Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, BAP, Project Number: 2016-1-TP2-1427, 11000 TL, Manager, 2016,Completed. 100
22. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on PPARa/β/g, c-jun, importin-a3, and RXRa expression in renal and cardiovascular tissues of endotoxemic rats, BAP, Project Number: BAP-SBE FB (ŞPŞ) 2014-3 YL, 10000 TL, Manager, 2015,Completed. 100
21. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on systemic miR-150, miR-223, and miR-297 levels in relation with activity of MyD88/TAK1/NF-kB pathway in endotoxemic rats, BAP, Project Number: BAP-SBE EMBB (ANS) 2012-4 DR, 20000 TL, Manager, 2013,Completed. 100
20. Determination of bisphenol-A level in the people in Mersin, BAP, Project Number: BAP-SBE FT (DB) 2011-7 YL, 10000 TL, Manager, 2012,Completed. 100
19. Investigation of the effect of a satble 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity , BAP, Project Number: BAP-ECZ F EMBB (BT) 2012-4 HD, 590 TL, Manager, 2012,Completed. 100
18. Investigation of the effect of a 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity in relation with proinflammatory cytokine production and MEK1/ERK1/2/NF-kB pathway in endotoxemic , BAP, Project Number: BAP-ECZ F FB (BT) 2010-5 B, 42000 TL, Manager, 2012,Completed. 100
17. Investigation of molecular mechanism of the interaction between nitric oxide synthase, cyclooxygenase and cytochrome P450 4A enzymes in cardiac, renal and vascular tissues of endotoxemic rats, TÜBİTAK, Project Number: 109S121, 280000 TL, Manager, 2012,Completed. 100
16. Contribution of COX-2 products to hypotension associated with increased NO production and decreased 20-HETE levels in endotoxemic rats, Novartis, Project Number: ---, 13000 TL, Manager, 2012,Completed. 0
15. Investigation of the effect of a stable 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity , BAP, Project Number: BAP-ECZ F MBB (BT) 2010-5 HD, 958 TL, Manager, 2011,Completed. 100
14. Investigation of the mechanism of preventive effect of selective 20-HETE agonist N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine on endotoxin-induced hypotension, BAP, Project Number: BAP SBE EMB (TC) 2008-6 DR, 10000 TL, Manager, 2010,Completed. 100
13. Effect of selective Rho-kinase inhibitor, Y-27632, on ischemia/reperfusion-induced target-organ skeletal muscle and end-organ kidney damage, BAP, Project Number: BAP SBE EMB (ANS) 2008-9 YL, 7847 TL, Manager, 2009,Completed. 100
12. Investigation of the preventive effect of selective 20-HETE agonist N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine on endotoxin-induced and nitric oxide-mediated hypotension and vascular hyporeactivity, Novartis, Project Number: ---, 10000 TL, Manager, 2009,Completed. 0
11. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 and inducible nitric oxide pathway in endotoxemic rats, TÜBİTAK, Project Number: 106S299, 70584 TL, Manager, 2009,Completed. 100
10. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 pathway in endotoxemic rats, BAP, Project Number: BAP SBE EMB (RBK) 2006-3 DR, 6000 TL, Manager, 2008,Completed. 100
9. Investigation of the effects of thalidomide in endotoxin-induced hyperalgesia, BAP, Project Number: BAP SBE EMB (OO) 2006-3 YL, 6000 TL, Manager, 2008,Completed. 100
8. Contribution of cytochrom P450 and cyclooxygenase products endotoxin-induced and nitric oxide-mediated hypotension, BAP, Project Number: BAP ECZF EMB (BT) 2006-3, 10000 TL, Manager, 2008,Completed. 100
7. Investigation of the importance of mitogen-activated extracellular signal regulated kinase (ERK1/2) pathway in endotoxin-induced and nitric oxide-mediated hypotension, BAP, Project Number: BAP ECZF EMB (BT) 2004-3, 21397 TL, Manager, 2006,Completed. 100
6. The investigation of the mechanisms of relationship among g protein-coupled alpha-adrenergic receptor/mitogen-activated kinases pathway, cytosolic phospholipase A2 and inducible nitric oxide synthase enzymes in endotoxin induced vascular hyporeactivity, BAP, Project Number: BAP SBE EMB (RBK) 2003-1 YL, 1900 TL, Manager, 2004,Completed. 100
5. Investigation of G protein-coupled receptor related changes induced by endotoxin in rat mesenteric artery, BAP, Project Number: BAP SBE EMB (EO) 2003-1 YL, 2000 TL, Manager, 2004,Completed. 100
4. Investigation of G protein-coupled receptor related changes induced by endotoxin in rat mesenteric artery, BAP, Project Number: BAP ECZ FMB (BT) 2002, 35000 TL, Manager, 2004,Completed. 100
3. Role of NF-kB, nitric oxide synthase, cyclooxygenase and poli ADP-ribose synthase in endotoxin-induced inflammatory hyperalgesia, Novartis, Project Number: ---, 3500 TL, Manager, 2004,Completed. 0
2. Role of tyrosine kinase, guanylyl cyclase, cyclooxygenase and polyADP-riboz sentaz on inducible nitric oxide synthase activity in kidney, heart and lung culture in mice, BAP, Project Number: EF-02/2001-01, 0 TL, Manager, 2001,Completed. 100
1. The role of inhibition of iNOS and COX-2 in septic shock, BAP, Project Number: EF-02/98-06, 0 TL, Manager, 1999,Completed. 100
12. Investigation of the involvement of mTOR on DOCA-salt-induced hypertension and related cardiovascular and renal pathophysiological changes in rats, TÜBİTAK, Project Number: 118S168, 15500 TL, Researcher, 2019,Completed. 50
11. Investigation of the Role of mTOR in Systemic Inflammatory Response in Zymosan-Induced Non-Septic Shock Model in Rats, BAP, Project Number: 2016-2-AP3-1900, 14450 TL, Researcher, 2017,Completed. 50
10. Investigation of the effect of Dtk inhibition on NF-kB signal transduction pathway in septic and nonseptic shock models, BAP, Project Number: BAP-ECZ F EMBF (SŞF) 2012-6 B, 56134 TL, Researcher, 2015,Completed. 50
9. Determination of some endocrine disruptors (bisphenol A (BPA), 4-t-octilphenol (4-t-OP) ve 4-nonilphenol (4-NP)) in human urine samples using liquid chromatography-mass spectrometry (LC/MS/MS) method, BAP, Project Number: BAP-ECZ F EMBB (DB) 2012-8 A, 24996 TL, Researcher, 2015,Completed. 50
8. Investigation of the possible role of some tropical viral and parasiter agents on the stimulation of inhibitor autoantibodies-induced ADAMTS-13 deficiency, BAP, Project Number: BAP-ECZ F TEB (MSS) 2010-3 A, 23996 TL, Researcher, 2014,Completed. 50
7. Mersin Chamber of Industry and Commerce (Project Partner). University-city cooperation action plan, Çukurova Kalkınma Ajansı, Project Number: TR62-12-DFD/004, 85284 TL, Researcher, 2013,Completed. 0
6. Investigation of the contribution of spleen tyrosine kinase to endotoxin-induced hypotension in rats, BAP, Project Number: BAP SBE F (MK) 2011-5 YL, 10000 TL, Researcher, 2012,Completed. 50
5. Investigation of the contribution of spleen tyrosine kinase to zymosan-induced hypotension in rats, BAP, Project Number: BAP SBE F (DG) 2011-5 YL, 10000 TL, Researcher, 2012,Completed. 50
4. Investigation of the relationship between ACE gene polymorphism and effect of ACE inhibition on myocardial injury during cardiopulmonary bypass, BAP, Project Number: BAP-TF CTB (NS) 2009-3, 17005 TL, Researcher, 2012,Completed. 50
3. Investigation of the relationship between IL-6, IL-8 and TNF-alpha gene polymorphism and myocardial injury during cardiopulmonary bypass in patients under ACE inhibitor therapy, BAP, Project Number: FEFBAP 2009-2, 4000 TL, Researcher, 2011,Completed. 50
2. Mechanism of apoptosis in hepatocellular carcinoma and effect of some benzimidazole derivatives on hepatocellular carcinoma, BAP, Project Number: BAP-SBE BA (AG) 2008-9 YL, 5969 TL, Researcher, 2009,Completed. 50
1. Investigation of the role and importance of pharmacological inhibition of cytosolic phospholipase A2 in sepsis pathogenesis, BAP, Project Number: BAP ECZ F EMB (KB) 2003-1, 17000 TL, Researcher, 2005,Completed. 50
11. Merve BİLİKTÜ, Investigation of the effect of inhibition of soluble epoxide hydrolase in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in experimental autoimmune encephalomyelitis model in mice, Graduate School of Health Sciences, Mersin University, Continue. 200
10. Ali CAĞLİ, Investigation of the effect of inhibition of soluble epoxide hydrolase in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, Graduate School of Health Sciences, Mersin University, Continue. 200
9. Furkan CEVHER, Evaluation of clinical effectiveness, quality of life, and satisfaction in patients with sickle cell anemia receiving hydroxyurea, Graduate School of Health Sciences, Mersin University, 2016, Completed. 200
8. Abdurrahman DOLUNAY, Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, Graduate School of Health Sciences, Mersin University, 2016, Completed. 200
7. Şefika Pınar ŞENOL, Investigation of the Effect of 5,14-HEDGE, a 20-HETE Mimetic, on PPARα/β/γ, c-Jun, Importin-α3, and RXRα Expression in Renal and Cardiovascular Tissues of Endotoxemic Rats, Graduate School of Health Sciences, Mersin University, 2014, Completed. 200
6. Şefika Pınar ŞENOL, Comparison of Iron Chelators in Terms of Compliance to Treatment in Patients with Thalassemia and Sickle Cell Anemia, Graduate School of Health Sciences, Ankara University, 2014, Completed. 200
5. Dilek BATTAL, Determination of bisphenol-A level in the people in Mersin, Graduate School of Health Sciences, Mersin University, 2012, Completed. 200
4. A. Nihal SARI, Effect of Selective Rho-Kinase Inhibitor Y-27632 on End Organ Kidney and Target Organ Skeletal Muscle Depend on Peripheric Ischemia/Reperfusion Damage, Graduate School of Health Sciences, Mersin University, 2010, Completed. 200
3. Orçun ÖZBAŞOĞLU, Investigation of the Effects of Thalidomide on Endotoxin-Induced Inflammatory Hyperalgesia, Graduate School of Health Sciences, Mersin University, 2009, Completed. 200
2. R. Belma KORKMAZ, The Investigation of the Mechanisms of Relationship among G Protein-Coupled Alpha-Adrenergic Receptor/Mitogen-Activated Kinases Pathway, Cytosolic Phospholipase A2 and Inducible Nitric Oxide Synthase Enzymes in Endotoxin Induced Vascular ..., Graduate School of Health Sciences, Mersin University, 2004, Completed. 200
1. Elif ÖZVEREN, Investigation of mechanisms of endotoxin-induced changes in G protein-related signalling pathway in rat mesenteric artery, Graduate School of Health Sciences, Mersin University, 2004, Completed. 200
5. Şefika Pınar ŞENOL, Investigation of the effect of selective RXRα agonist, bexarotene, on TLR4/MyD88/TAK1/NF-κB/COX-2 pathway in relation to proinflammatory cytokine production in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, Graduate School of Health Sciences, Mersin University, Continue. 400
4. Dilşah Ezgi YILMAZ, Investigation of the effect of docosahexaenoic acid on TRAF6/IKK/NF-kB pathway in relation to antiinflammatory NLRX1 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, Graduate School of Health Sciences, Mersin University, Continue. 400
3. A. Nihal SARI, Investigation of the Effect of 20-HETE Analog, 5,14-HEDGE, on Systemic miR-150, miR-223, and miR-297 Levels in Relation with Activity of MyD88/TAK1/NF-kB Pathway in Endotoxemic Rats, Graduate School of Health Sciences, Mersin University, 2013, Completed. 400
2. Tuba CÜEZ, Investigation of the Mechanism of Preventive Effect of 20-HETE Agonist N-[20-Hydroxyeicosa-5(Z),14(Z)-Dienoyl]Glycine on Endotoxin-Induced Hypotension, Graduate School of Health Sciences, Mersin University, 2010, Completed. 400
1. R. Belma KORKMAZ, Investigation of mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 and inducible nitric oxide synthase pathway in endotoxemic rats, Graduate School of Health Sciences, Mersin University, 2009, Completed. 400
1. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY , EDITOR, ISSN : 1875-614X, E-ISSN : 1871-5230, 2004-01-01 - 2015-12-31. 2000
2. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY , ASSOCIATE EDITOR, ISSN : 1875-614X, E-ISSN : 1871-5230, 2016-01-01 - Continue. 1000
3. AUSTIN JOURNAL OF PHARMACOLOGY & THERAPEUTICS , PUBLICATION BOARD MEMBER, E-ISSN : 2373-6208, 2014-05-22 - Continue. 250
4. INTERNATIONAL JOURNALS OF CANCER STUDIES & RESEARCH , PUBLICATION BOARD MEMBER, E-ISSN : 2167-9118, 2012-11-26 - Continue. 250
5. PROSTAGLANDINS AND OTHER LIPID MEDIATORS , PUBLICATION BOARD MEMBER, E-ISSN : 1098-8823, 2012-03-22 - Continue. 500
6. TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES - TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , ADVISORY BOARD MEMBER, E-ISSN : 1300-0292, 2010-02-01 - Continue. 250
1. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , PUBLICATION BOARD MEMBER, ISSN : 1309–8004, 2010-07-21 - Continue. 125
2. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI , ADVISORY BOARD MEMBER, E-ISSN : 2146-944X, 2010-10-22 - Continue. 65
1. TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES - TüRKIYE KLINIKLERI TıP BILIMLERI DERGISI , [ 2010 : 9 ] . 45
2. ACS MEDICINAL CHEMISTRY LETTERS , [ 2016 : 1 ] . 5
3. AFRICAN JOURNAL OF INTERNAL MEDICINE , [ 2012 : 1 ] . 5
4. AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , [ 2012 : 1 ] [ 2009 : 2 ] . 15
5. BIOLOGICAL RESEARCH FOR NURSING , [ 2008 : 1 ] . 5
6. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , [ 2015 : 1 ] . 5
7. CELL BIOLOGY INTERNATIONAL , [ 2006 : 1 ] . 5
8. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , [ 2015 : 1 ] [ 2016 : 1 ] . 10
9. CLINICAL SCIENCE , [ 2017 : 1 ] . 5
10. CLINICAL AND EXPERIMENTAL PATHOLOGY , [ 2013 : 1 ] . 5
11. CURRENT DRUG METABOLISM , [ 2013 : 1 ] [ 2012 : 1 ] . 10
12. CURRENT PHARMACEUTICAL DESIGN , [ 2017 : 1 ] . 5
13. EXPERIMENTAL AND THERAPEUTIC MEDICINE , [ 2017 : 1 ] . 5
14. INFLAMMATION RESEARCH , [ 2009 : 2 ] [ 2019 : 1 ] . 15
15. INNATE IMMUNITY , [ 2016 : 2 ] . 10
16. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , [ 2017 : 2 ] . 10
17. INTERNATIONAL JOURNAL OF MEDICINE AND MEDICAL SCIENCES , [ 2009 : 2 ] . 10
18. INTERNATIONAL RESEARCH JOURNAL OF MICROBIOLOGY , [ 2010 : 1 ] . 4
19. JOURNAL OF APPLIED BIOPHARMACEUTICS AND PHARMACOKINETICS , [ 2014 : 1 ] [ 2013 : 3 ] . 16
20. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS , [ 2015 : 1 ] . 5
21. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE , [ 2018 : 1 ] . 5
22. JOURNAL OF ETHNOPHARMACOLOGY , [ 2014 : 1 ] [ 2012 : 7 ] [ 2011 : 13 ] [ 2010 : 16 ] [ 2009 : 6 ] [ 2008 : 2 ] [ 2007 : 11 ] [ 2006 : 1 ] . 285
23. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY , [ 2017 : 2 ] . 10
24. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , [ 2015 : 2 ] [ 2013 : 2 ] [ 2016 : 1 ] . 25
25. JOURNAL OF PULMONARY & RESPIRATORY MEDICINE , [ 2013 : 1 ] . 4
26. LIFE SCIENCES , [ 2014 : 1 ] . 5
27. MARMARA PHARMACEUTICAL JOURNAL , [ 2016 : 1 ] . 4
28. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , [ 2007 : 1 ] . 5
29. MICROBIOLOGICAL PATHOGENESIS , [ 2018 : 1 ] . 4
30. MINI REVIEWS IN MEDICINAL CHEMISTRY , [ 2008 : 1 ] . 5
31. NITRIC OXIDE: BIOLOGY AND CHEMISTRY , [ 2015 : 3 ] [ 2014 : 1 ] [ 2013 : 3 ] [ 2012 : 4 ] [ 2007 : 1 ] [ 2006 : 3 ] [ 2005 : 1 ] . 80
32. PHARMACOLOGICAL RESEARCH , [ 2011 : 1 ] [ 2006 : 2 ] . 15
33. PROSTAGLANDINS AND OTHER LIPID MEDIATORS , [ 2015 : 2 ] [ 2014 : 2 ] [ 2013 : 1 ] [ 2011 : 1 ] [ 2016 : 2 ] [ 2017 : 1 ] . 45
34. THE ANATOLIAN JOURNAL OF CARDIOLOGY , [ 2015 : 1 ] . 5
35. TOXICOLOGY AND APPLIED PHARMACOLOGY , [ 2014 : 1 ] . 5
36. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY-TüRK GöğüS KALP DAMAR CERRAHISI DERGISI , [ 2015 : 2 ] [ 2013 : 1 ] [ 2016 : 1 ] . 20
37. VASCULAR PHARMACOLOGY , [ 2014 : 1 ] . 5
1. GAZI MEDICAL JOURNAL , [ 2008 : 1 ] . 1
2. HACETTEPE UNIVERSITESI ECZACILIK FAKULTESI DERGISI , [ 2009 : 1 ] . 1
3. KLINIK PSIKIYATRI DERGISI , [ 2007 : 1 ] . 1
4. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI , [ 2015 : 2 ] . 2
5. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , [ 2014 : 2 ] [ 2013 : 1 ] [ 2012 : 1 ] [ 2010 : 2 ] [ 2008 : 1 ] . 7
6. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI , [ 2013 : 1 ] [ 2012 : 2 ] [ 2011 : 3 ] [ 2017 : 1 ] . 7
1. , 2012-09-19, Budapeşte, Hungary. 50
2. WORLD ACADEMY OF SCIENCE, ENGINEERING, AND TECHNOLOGY, 2017-05-14, Amsterdam, Netherlands. 0
1. , 2008-04-14, Ankara, Turkey. 50
2. , 2010-04-14, Ankara, Turkey. 50
3. Journal of Pharmacy, 2015-11-27, İstanbul, Turkey. 0
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ503 | Management of Community Pharmacy | Faculty of Pharmacy | Pharmacy | 1-0-1 |
| Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 504 | Drugs Affecting Renal System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ422 | Pharmacy Law & Administration | Faculty of Pharmacy | Pharmacy | 4-0-4 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ432 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Spring | ECZ430 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 1-2-2 |
| Spring | FMK 605 | Pharmacology of Smooth Muscie and Skelet... | Institute of Health Sciences | Pharmacy Pharmacology | 2-2-3 |
| Spring | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
| Fall | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Fall | FMK 623 | Inflammation and Antiinflammatory Drugs | Institute of Health Sciences | Pharmacy Pharmacology | 1-0-1 |
| Fall | FMK 606 | Pharmacology of Communication Between Au... | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 504 | Drugs Affecting Renal System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 1-2-2 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ430 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ432 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | FMK 504 | Drugs Affecting Renal System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | SEM DR | Seminar I | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Fall | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 608 | Pharmacokinetics | Institute of Health Sciences | Pharmacy Pharmacology | 3-0-3 |
| Fall | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ128 | Introduction To Pharmacy Profession and ... | Faculty of Pharmacy | Pharmacy | 4-0-4 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ422 | Pharmacy Law & Administration | Faculty of Pharmacy | Pharmacy | 4-0-4 |
| Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-3 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | FMK 506 | Drugs Affecting Endocrine System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | SEM DR | Seminar II | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 2-6-5 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ509 | Hospital Pharmacy Practice | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 605 | Pharmacology of Smooth Muscie and Skelet... | Institute of Health Sciences | Pharmacy Pharmacology | 2-2-3 |
| Fall | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 603 | Mechanisms For Searching and Evaluation ... | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | ILC201 | Drug Information I | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ430 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ432 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 0-3-1 |
| Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
| Spring | FMK 601 | Mechanisms For Drug Action | Institute of Health Sciences | Pharmacy Pharmacology | 3-0-3 |
| Spring | SEM DR | Seminar I | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | FMK 607 | Experimental Pharmacology II | Institute of Health Sciences | Pharmacy Pharmacology | 2-4-4 |
| Spring | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ503 | Management of Community Pharmacy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 2-6-4 |
| Fall | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ513 | Quality Assurance In Industrial Pharmacy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 605 | Pharmacology of Smooth Muscie and Skelet... | Institute of Health Sciences | Pharmacy Pharmacology | 2-2-3 |
| Fall | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Fall | FMK 603 | Mechanisms For Searching and Evaluation ... | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 501 | General Pharmacology | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | FMK 502 | Drugs Affecting Autonomic Nervous System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Fall | ILC201 | Drug Information I | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | FMK 515 | Scientific Presentation and Writing Tech... | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
| Spring | FMK 603 | Mechanisms For Searching and Evaluation ... | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | FMK 506 | Drugs Affecting Endocrine System | Institute of Health Sciences | Pharmacy Pharmacology | 2-0-2 |
| Spring | FMK 801 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | FMK 802 | Specialty Area | Institute of Health Sciences | Department of Pharmacy Pharmac... | 4-0-4 |
| Spring | ILC202 | Pharmaceutical Information II | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Fall | ECZ441 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 0-3-1 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ439 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ505 | Community Pharmacy Practice | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 501 | General Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | FMK 617 | Professional Ethics | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 1-0-1 |
| Fall | FMK 610 | Pharmacology of Communication Between Ho... | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | FMK 504 | Drugs Affecting Renal System | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | FMK 506 | Drugs Affecting Endocrine System | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | ILC201 | Drug Information I | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | FMK 504 | Drugs Affecting Renal System | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Spring | FMK 602 | Pharmacology Communication Between Neuro... | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Spring | FMK 501 | General Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Spring | FMK 601 | Mechanisms For Drug Action | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 3-0-3 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ503 | Management of Community Pharmacy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 512 | Experimental Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-4-4 |
| Fall | FMK 501 | General Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | FMK 614 | Seminar | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 0-0-0 |
| Spring | FMK 504 | Drugs Affecting Renal System | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Spring | FMK 604 | Experimental Pharmacology I | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-4-4 |
| Spring | FMK 501 | General Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Spring | FMK 601 | Mechanisms For Drug Action | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 3-0-3 |
| Spring | ILC202 | Pharmaceutical Information II | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Spring | ILC202 | Ilac Bilgisi II | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | FMK 512 | Experimental Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-4-4 |
| Fall | FMK 501 | General Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | FMK 504 | Drugs Affecting Renal System | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-0-2 |
| Fall | ILC201 | Drug Information I | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Fall | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Summer | ILC201 | Ilac Bilgisi I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 4-0-4 |
| Summer | ILC201 | Drug Information I | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ430 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ432 | Pharmaceutical Care - Clinical Pharmacy ... | Faculty of Pharmacy | Pharmacy | 0-3-1 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | FMK 512 | Experimental Pharmacology | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 2-4-4 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ503 | Management of Community Pharmacy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | EHP203 | Study of Drugs I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 6-0-6 |
| Fall | TTP231 | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ505 | Community Pharmacy Practice | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | FMK 626 | Pain and Analgesics | Graduate School of Health Scie... | PHARMACY PHARMACOLOGY | 1-0-1 |
| Fall | EHP203 | Study of Drugs I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 6-0-6 |
| Fall | TTP231 | Vocational School of Mersin | Medical Promotion and Marketin... | 4-0-4 | |
| Summer | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
| Spring | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Spring | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Spring | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ503 | Management of Community Pharmacy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ435 | Pharmacology Practise | Faculty of Pharmacy | Pharmacy | 0-2-1 |
| Fall | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Fall | ECZ411 | Pharmacology IV | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Fall | EHP203 | Study of Drugs I | Vocational School of Mersin | Pharmacy Services ( Distance E... | 6-0-6 |
| Summer | ECZ325 | Pharmacology II | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Summer | ECZ420 | Pharmacotherapy | Faculty of Pharmacy | Pharmacy | 2-0-2 |
| Summer | ECZ212 | Pharmacology I | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Summer | ECZ231 | Physiology | Faculty of Pharmacy | Pharmacy | 3-0-3 |
| Summer | ECZ314 | Pharmacology Iii | Faculty of Pharmacy | Pharmacy | 2-0-2 |
